个人科研网厅 | | 帮助
高级检索
当前位置： 首页 > 详情页

Author Correction: LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer (Nature Communications, (2019), 10, 1, (5494), 10.1038/s41467-019-13532-4)

| 认领 | 导出 | |

文献详情

资源类型：
WOS体系：
Pubmed体系：

收录情况： ◇ 自然指数

作者：
Li, Q[a,b,c] * ; Liu, B[c] ; Chao, H.-P[c] ; Ji, Y[a] ; Lu, Y[c] ; Mehmood, R[a] ; Jeter, C[c] ; Chen, T[c] ; Moore, J.R[c] ; Li, W[c] ; Liu, C[c] ; Rycaj, K[a,c] ; Tracz, A[a] ; Kirk, J[a] ; Calhoun-Davis, T[c] ; Xiong, J[a,c] ; Deng, Q[a,c] ; Huang, J[d] ; Foster, B.A[a] ; Gokhale, A[a] ; Chen, X[a,c,e] ; Tang, D.G[a,c,f] ;
单位： [a]Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, United States [b]State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) and Key Laboratory for Oral Biomedicine of Ministry of Education (KLOBM), School and Hospital of Stomatology, Wuhan University, Wuhan, 430079, China [c]Department of Epigenetics and Molecular Carcinogenesis, University of Texas M.D. Anderson Cancer Center, Science Park, Smithville, TX 78957, United States [d]Department of Pathology, Duke University of School of Medicine, Durham, NC 27710, United States [e]Department of Oncology, Tongji Hospital, Tongji Medical School, Huazhong University of Science and Technology (HUST), Wuhan, 430030, China [f]Cancer Stem Cell Institute, Research Center for Translational Medicine, East Hospital, Tongji University School of Medicine, Shanghai, 200120, China
出处：
DOI： 10.1038/s41467-020-16615-9

摘要：
An amendment to this paper has been published and can be accessed via a link at the top of the paper. © 2020, The Author(s).

语种：
外文
WOS：
PubmedID：
中科院(CAS)分区：
出版当年[2019]版：
大类 | 1 区 综合性期刊
小类 | 1 区 综合性期刊
最新[2025]版：
大类 | 1 区 综合性期刊
小类 | 1 区 综合性期刊
第一作者：
第一作者单位： [a]Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, United States [b]State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) and Key Laboratory for Oral Biomedicine of Ministry of Education (KLOBM), School and Hospital of Stomatology, Wuhan University, Wuhan, 430079, China [c]Department of Epigenetics and Molecular Carcinogenesis, University of Texas M.D. Anderson Cancer Center, Science Park, Smithville, TX 78957, United States
通讯作者：
通讯机构： [a]Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, United States [c]Department of Epigenetics and Molecular Carcinogenesis, University of Texas M.D. Anderson Cancer Center, Science Park, Smithville, TX 78957, United States [e]Department of Oncology, Tongji Hospital, Tongji Medical School, Huazhong University of Science and Technology (HUST), Wuhan, 430030, China [f]Cancer Stem Cell Institute, Research Center for Translational Medicine, East Hospital, Tongji University School of Medicine, Shanghai, 200120, China
推荐引用方式(GB/T 7714)：
Li Q,Liu B,Chao H.-P,et al.Author Correction: LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer (Nature Communications, (2019), 10, 1, (5494), 10.1038/s41467-019-13532-4)[J].Nature communications.2020,11(1):2895.doi:10.1038/s41467-020-16615-9.
APA：
Li, Q,Liu, B,Chao, H.-P,Ji, Y,Lu, Y...&Tang, D.G.(2020).Author Correction: LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer (Nature Communications, (2019), 10, 1, (5494), 10.1038/s41467-019-13532-4).Nature communications,11,(1)
MLA：
Li, Q,et al."Author Correction: LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer (Nature Communications, (2019), 10, 1, (5494), 10.1038/s41467-019-13532-4)".Nature communications 11..1(2020):2895

资源点击量：432 今日访问量：0 总访问量：413 更新日期：2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有：重庆聚合科技有限公司 渝ICP备12007440号-3 地址：重庆市两江新区泰山大道西段8号坤恩国际商务中心16层（401121）